Computer Product Briefs

Until recently, computer incompatibility and expense have hampered U.S. astronomers from easily accessing a valuable, extensively stocked French database called SIMBAD. But NASA and NSF have teamed up to pay for a permanent network hookup, circuit costs, and charges for scientists' use of the database itself. SIMBAD (Set of Identifications, Measurements, and Bibliography for Astronomical Data), maintained in Strasbourg, France, makes it possible for an astronomer to look up an astronomical objec

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Until recently, computer incompatibility and expense have hampered U.S. astronomers from easily accessing a valuable, extensively stocked French database called SIMBAD. But NASA and NSF have teamed up to pay for a permanent network hookup, circuit costs, and charges for scientists' use of the database itself. SIMBAD (Set of Identifications, Measurements, and Bibliography for Astronomical Data), maintained in Strasbourg, France, makes it possible for an astronomer to look up an astronomical object, such as a star or the recent supernova, by its astronomical designation. The scientists can access nearly all known information and a listing of papers published about a given subject since 1950. The Smithsonian Astrophysical Observatory, Cambridge, Mass., will register U.S. astronomers and provide them with passwords.

Asymmetric Synthesis Database

Molecular Design Limited has announced that it is developing an asymmetric synthesis database called CHIRAS for use with REACCS, the company's reaction access system. Planning to release the database during the last quarter of 1988, the company claims that CHIRAS will be of value to researchers whose work entails producing organic molecules with controlled absolute and relative stereochemistry. Prospective customers, the developer feels, would include, for example, investigators working in the pharmaceutical or agrochemical industries. The initial release will include data on approximately 6,000 reactions, with an additional 6,000 expected to be added by the end of 1989, with the total covering the chemical literature from 1975 to 1987. The company plans to release yearly updates thereafter.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies